Multiple Myeloma Therapy Market, Global Outlook and Forecast 2023-2029

Report ID: MMG175103 | Category: Pharma & Healthcare | Pages: 63 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.
This report aims to provide a comprehensive presentation of the global market for Multiple Myeloma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Myeloma Therapy. This report contains market size and forecasts of Multiple Myeloma Therapy in global, including the following market information:
Global Multiple Myeloma Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Multiple Myeloma Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Targeted Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Multiple Myeloma Therapy include Sanofi, Celgene, Johnson & Johnson, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc., Novartis AG and Millennium Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multiple Myeloma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiple Myeloma Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Multiple Myeloma Therapy Market Segment Percentages, by Type, 2022 (%)
    Targeted Therapy
    Chemotherapy
    Radiotherapy
    Bone Marrow Transplant
    Others
Global Multiple Myeloma Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Multiple Myeloma Therapy Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Clinic
Global Multiple Myeloma Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Multiple Myeloma Therapy Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiple Myeloma Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Multiple Myeloma Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sanofi
    Celgene
    Johnson & Johnson
    GlaxoSmithKline plc
    F. Hoffmann-La Roche Ltd
    AbbVie Inc.
    Amgen Inc.
    Novartis AG
    Millennium Pharmaceuticals
    Innate Pharma SA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multiple Myeloma Therapy, market overview.
Chapter 2: Global Multiple Myeloma Therapy market size in revenue.
Chapter 3: Detailed analysis of Multiple Myeloma Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multiple Myeloma Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Multiple Myeloma Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Multiple Myeloma Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Multiple Myeloma Therapy Overall Market Size
    2.1 Global Multiple Myeloma Therapy Market Size: 2022 VS 2029
    2.2 Global Multiple Myeloma Therapy Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Multiple Myeloma Therapy Players in Global Market
    3.2 Top Global Multiple Myeloma Therapy Companies Ranked by Revenue
    3.3 Global Multiple Myeloma Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Multiple Myeloma Therapy Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Multiple Myeloma Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Multiple Myeloma Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Multiple Myeloma Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Multiple Myeloma Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Multiple Myeloma Therapy Market Size Markets, 2022 & 2029
        4.1.2 Targeted Therapy
        4.1.3 Chemotherapy
        4.1.4 Radiotherapy
        4.1.5 Bone Marrow Transplant
        4.1.6 Others
    4.2 By Type - Global Multiple Myeloma Therapy Revenue & Forecasts
        4.2.1 By Type - Global Multiple Myeloma Therapy Revenue, 2018-2023
        4.2.2 By Type - Global Multiple Myeloma Therapy Revenue, 2024-2029
        4.2.3 By Type - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Multiple Myeloma Therapy Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Clinic
    5.2 By Application - Global Multiple Myeloma Therapy Revenue & Forecasts
        5.2.1 By Application - Global Multiple Myeloma Therapy Revenue, 2018-2023
        5.2.2 By Application - Global Multiple Myeloma Therapy Revenue, 2024-2029
        5.2.3 By Application - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Multiple Myeloma Therapy Market Size, 2022 & 2029
    6.2 By Region - Global Multiple Myeloma Therapy Revenue & Forecasts
        6.2.1 By Region - Global Multiple Myeloma Therapy Revenue, 2018-2023
        6.2.2 By Region - Global Multiple Myeloma Therapy Revenue, 2024-2029
        6.2.3 By Region - Global Multiple Myeloma Therapy Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Multiple Myeloma Therapy Revenue, 2018-2029
        6.3.2 US Multiple Myeloma Therapy Market Size, 2018-2029
        6.3.3 Canada Multiple Myeloma Therapy Market Size, 2018-2029
        6.3.4 Mexico Multiple Myeloma Therapy Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Multiple Myeloma Therapy Revenue, 2018-2029
        6.4.2 Germany Multiple Myeloma Therapy Market Size, 2018-2029
        6.4.3 France Multiple Myeloma Therapy Market Size, 2018-2029
        6.4.4 U.K. Multiple Myeloma Therapy Market Size, 2018-2029
        6.4.5 Italy Multiple Myeloma Therapy Market Size, 2018-2029
        6.4.6 Russia Multiple Myeloma Therapy Market Size, 2018-2029
        6.4.7 Nordic Countries Multiple Myeloma Therapy Market Size, 2018-2029
        6.4.8 Benelux Multiple Myeloma Therapy Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Multiple Myeloma Therapy Revenue, 2018-2029
        6.5.2 China Multiple Myeloma Therapy Market Size, 2018-2029
        6.5.3 Japan Multiple Myeloma Therapy Market Size, 2018-2029
        6.5.4 South Korea Multiple Myeloma Therapy Market Size, 2018-2029
        6.5.5 Southeast Asia Multiple Myeloma Therapy Market Size, 2018-2029
        6.5.6 India Multiple Myeloma Therapy Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Multiple Myeloma Therapy Revenue, 2018-2029
        6.6.2 Brazil Multiple Myeloma Therapy Market Size, 2018-2029
        6.6.3 Argentina Multiple Myeloma Therapy Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Multiple Myeloma Therapy Revenue, 2018-2029
        6.7.2 Turkey Multiple Myeloma Therapy Market Size, 2018-2029
        6.7.3 Israel Multiple Myeloma Therapy Market Size, 2018-2029
        6.7.4 Saudi Arabia Multiple Myeloma Therapy Market Size, 2018-2029
        6.7.5 UAE Multiple Myeloma Therapy Market Size, 2018-2029
7 Multiple Myeloma Therapy Companies Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Multiple Myeloma Therapy Major Product Offerings
        7.1.4 Sanofi Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.1.5 Sanofi Key News & Latest Developments
    7.2 Celgene
        7.2.1 Celgene Company Summary
        7.2.2 Celgene Business Overview
        7.2.3 Celgene Multiple Myeloma Therapy Major Product Offerings
        7.2.4 Celgene Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.2.5 Celgene Key News & Latest Developments
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Company Summary
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Multiple Myeloma Therapy Major Product Offerings
        7.3.4 Johnson & Johnson Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.3.5 Johnson & Johnson Key News & Latest Developments
    7.4 GlaxoSmithKline plc
        7.4.1 GlaxoSmithKline plc Company Summary
        7.4.2 GlaxoSmithKline plc Business Overview
        7.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Major Product Offerings
        7.4.4 GlaxoSmithKline plc Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.4.5 GlaxoSmithKline plc Key News & Latest Developments
    7.5 F. Hoffmann-La Roche Ltd
        7.5.1 F. Hoffmann-La Roche Ltd Company Summary
        7.5.2 F. Hoffmann-La Roche Ltd Business Overview
        7.5.3 F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Major Product Offerings
        7.5.4 F. Hoffmann-La Roche Ltd Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.5.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
    7.6 AbbVie Inc.
        7.6.1 AbbVie Inc. Company Summary
        7.6.2 AbbVie Inc. Business Overview
        7.6.3 AbbVie Inc. Multiple Myeloma Therapy Major Product Offerings
        7.6.4 AbbVie Inc. Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.6.5 AbbVie Inc. Key News & Latest Developments
    7.7 Amgen Inc.
        7.7.1 Amgen Inc. Company Summary
        7.7.2 Amgen Inc. Business Overview
        7.7.3 Amgen Inc. Multiple Myeloma Therapy Major Product Offerings
        7.7.4 Amgen Inc. Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.7.5 Amgen Inc. Key News & Latest Developments
    7.8 Novartis AG
        7.8.1 Novartis AG Company Summary
        7.8.2 Novartis AG Business Overview
        7.8.3 Novartis AG Multiple Myeloma Therapy Major Product Offerings
        7.8.4 Novartis AG Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.8.5 Novartis AG Key News & Latest Developments
    7.9 Millennium Pharmaceuticals
        7.9.1 Millennium Pharmaceuticals Company Summary
        7.9.2 Millennium Pharmaceuticals Business Overview
        7.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Major Product Offerings
        7.9.4 Millennium Pharmaceuticals Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.9.5 Millennium Pharmaceuticals Key News & Latest Developments
    7.10 Innate Pharma SA
        7.10.1 Innate Pharma SA Company Summary
        7.10.2 Innate Pharma SA Business Overview
        7.10.3 Innate Pharma SA Multiple Myeloma Therapy Major Product Offerings
        7.10.4 Innate Pharma SA Multiple Myeloma Therapy Revenue in Global Market (2018-2023)
        7.10.5 Innate Pharma SA Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Multiple Myeloma Therapy Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?